EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for VOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -83.39
March 31, 2026 -333.48
December 31, 2025 -328.63
September 30, 2025 -381.91
June 30, 2025 -260.68
March 31, 2025 -9.849
December 31, 2024 -10.04
September 30, 2024 -1.650
June 30, 2024 -1.738
March 31, 2024 -1.778
December 31, 2023 -1.754
September 30, 2023 -1.881
June 30, 2023 -2.016
March 31, 2023 -2.148
Date Value
December 31, 2022 -2.328
September 30, 2022 -2.305
June 30, 2022 -2.182
March 31, 2022 -2.101
December 31, 2021 -1.898
September 30, 2021 -1.887
June 30, 2021 -1.761
March 31, 2021 -1.503
December 31, 2020 -1.327
September 30, 2020 -0.9652
June 30, 2020 -0.7005
March 31, 2020 -0.4609
December 31, 2019 -0.2302
September 30, 2019 -0.1117

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Agenus, Inc. 2.651
Amgen, Inc. 16.10
Anika Therapeutics, Inc. -0.2741
BioCryst Pharmaceuticals, Inc. -1.504
Imunon, Inc. -3.843